Ph.D. Marshall Hayward - 02 Jun 2025 Form 4 Insider Report for JUPITER NEUROSCIENCES, INC. (JUNS)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
13 Jul 2026, 16:00:17 UTC
Prior SEC filing
08 Nov 2024
Next SEC filing
04 Jun 2026
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Marshall A. Hayward

Key filing fact

Ph.D. Marshall Hayward filed Form 4 for JUPITER NEUROSCIENCES, INC. (JUNS) on 13 Jul 2026.

Key facts

  • This page summarizes Ph.D. Marshall Hayward's Form 4 filing for JUPITER NEUROSCIENCES, INC. (JUNS).
  • 6 reported transactions and 3 derivative rows are listed below.
  • Accepted by SEC: 13 Jul 2026, 16:00.

Change

  • Previous filing in this sequence was filed on 08 Nov 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001891872 Primary reporting owner

Hayward Marshall A.

Relationship
Chief Scientific Officer, Director
Address
C/O JUPITER NEUROSCIENCES, INC., 11621 KEW GARDENS AVE, SUITE 210, PALM BEACH GARDENS
Signature
/s/ Marshall A. Hayward
Signature date
13 Jul 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

JUNS transaction

Common Stock

Options Exercise

Transaction value
Shares
+389,793
Change %
+20%
Price
Shares after
2,370,675
Date
02 Jun 2025
Ownership
Direct
Footnotes
F1
JUNS transaction

Common Stock

Options Exercise

Transaction value
Shares
+399,402
Change %
+17%
Price
Shares after
2,770,077
Date
02 Jun 2025
Ownership
Direct
Footnotes
F1
JUNS transaction

Common Stock

Options Exercise

Transaction value
Shares
+225,000
Change %
+8.1%
Price
Shares after
2,995,077
Date
02 Mar 2026
Ownership
Direct
Footnotes
F3

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

JUNS transaction Derivative

Restricted Stock Units

Options Exercise

Transaction value
Shares
-389,793
Change %
-100%
Price
$0.000000*
Shares after
0
Date
02 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
389,793
Exercise price
Footnotes
F1, F2
JUNS transaction Derivative

Restricted Stock Award

Options Exercise

Transaction value
Shares
-399,402
Change %
-100%
Price
$0.000000*
Shares after
0
Date
02 Jun 2025
Ownership
Direct
Underlying class
Common Stock
Underlying amount
399,402
Exercise price
Footnotes
F1, F2
JUNS transaction Derivative

Stock Option (right to buy)

Options Exercise

Transaction value
Shares
-225,000
Change %
-100%
Price
$0.000000*
Shares after
0
Date
02 Mar 2026
Ownership
Direct
Underlying class
Common stock
Underlying amount
225,000
Exercise price
$0.0100
Footnotes
F3
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 3 footnotes

Footnote F1

These securities convert into common stock on a one-for-one basis.

Footnote F2

These awards vested on the expiration of the lock-up period for the Issuer's initial public offering.

Footnote F3

The shares underlying this option vested 100% on January 1, 2016 under the Company's 2016 Equity Incentive Plan.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .